4/17/24 16:30 | 4/15/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 61.24 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
3/19/24 16:30 | 3/15/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -1,200 | 60.00 | 0 | -20 | -15 | 114 | D | | | | | | | | | | | | | | |
3/15/24 16:30 | 3/13/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 60.48 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
3/11/24 16:30 | 3/7/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -1,117 | 61.96 | 0 | -18 | -15 | 103 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | M.dm | 67 | 16.30 | 0 | 4 | 8 | 58 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S.dm | -262 | 64.06 | 0 | -4 | -7 | 58 | D | | | | | | | | | | | | | | |
3/6/24 17:15 | 3/4/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | M.d | 444 | 19.85 | 0 | 22 | 63 | 58 | D | | | | | | | | | | | | | | |
3/6/24 17:15 | 3/4/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S.d | -1,465 | 65.42 | 0 | -22 | -28 | 58 | D | | | | | | | | | | | | | | |
3/5/24 20:28 | 3/4/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | S | -6,130 | 65.31 | 0 | -94 | -13 | 631 | D | | | | | | | | | | | | | | |
2/15/24 16:30 | 2/13/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -19 | 55.31 | 0 | 0 | -1 | 58 | D | | | | | | | | | | | | | | |
1/18/24 16:30 | 1/16/24 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -19 | 56.01 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
12/19/23 17:00 | 12/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -782 | 78.24 | 0 | -10 | -9 | 103 | D | | | | | | | | | | | | | | |
12/15/23 16:30 | 12/13/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -26 | 75.62 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
11/20/23 16:30 | 11/16/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -102 | 67.96 | 0 | -2 | -2 | 89 | D | | | | | | | | | | | | | | |
11/15/23 16:32 | 11/13/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S | -751 | 63.72 | 0 | -12 | -2 | 697 | D | | | | | | | | | | | | | | |
11/15/23 16:30 | 11/13/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -22 | 63.57 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
10/13/23 17:03 | 6/2/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baylor-Henry Minnie | MA | D | | S | -1 | 86.22 | 0 | 0 | -27 | 0 | I | | | | | | | | | | | | | | |
9/19/23 16:30 | 9/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | M.d | 51 | 17.79 | 0 | 3 | 4 | 66 | D | | | | | | | | | | | | | | |
9/19/23 16:30 | 9/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S.d | -189 | 66.43 | 0 | -3 | -4 | 66 | D | | | | | | | | | | | | | | |
8/23/23 16:30 | 8/21/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -27 | 66.10 | 0 | 0 | 0 | 90 | D | | | | | | | | | | | | | | |
8/22/23 16:30 | 8/18/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -98 | 65.19 | 0 | -2 | -2 | 90 | D | | | | | | | | | | | | | | |
8/17/23 16:30 | 8/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -685 | 68.52 | 0 | -10 | -8 | 108 | D | | | | | | | | | | | | | | |
8/15/23 17:35 | 8/11/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S | -751 | 68.58 | 0 | -11 | -2 | 708 | D | | | | | | | | | | | | | | |
8/15/23 16:54 | 8/11/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -292 | 67.93 | 0 | -4 | -6 | 66 | D | | | | | | | | | | | | | | |
7/21/23 16:30 | 7/19/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -159 | 90.87 | 0 | -2 | -3 | 60 | D | | | | | | | | | | | | | | |
5/22/23 18:47 | 5/18/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -147 | 97.93 | 0 | -2 | -2 | 92 | D | | | | | | | | | | | | | | |
5/17/23 16:31 | 5/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -38 | 99.36 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
5/17/23 16:30 | 5/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -994 | 99.36 | 0 | -10 | -8 | 118 | D | | | | | | | | | | | | | | |
5/15/23 18:34 | 5/11/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -604 | 98.82 | 0 | -6 | -8 | 72 | D | | | | | | | | | | | | | | |
4/19/23 17:33 | 4/17/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -34 | 88.67 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
4/19/23 17:32 | 4/17/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S | -188 | 88.67 | 0 | -2 | -3 | 67 | D | | | | | | | | | | | | | | |
4/5/23 16:30 | 4/3/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S | -302 | 82.09 | 0 | -4 | -5 | 69 | D | | | | | | | | | | | | | | |
3/29/23 21:11 | 3/27/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | M.ad | 850 | 19.11 | 0 | 44 | 7 | 719 | D | | | | | | | | | | | | | | |
3/29/23 21:11 | 3/27/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S.ad | -3,593 | 80.77 | 0 | -44 | -6 | 719 | D | | | | | | | | | | | | | | |
3/29/23 17:51 | 3/27/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -1,078 | 81.13 | 0 | -13 | -41 | 19 | D | | | | | | | | | | | | | | |
3/29/23 17:51 | 3/27/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | M.d | 850 | 19.11 | 0 | 44 | 7 | 719 | I | | | | | | | | | | | | | | |
3/29/23 17:51 | 3/27/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S.d | -3,593 | 80.77 | 0 | -44 | -6 | 719 | I | | | | | | | | | | | | | | |
3/29/23 17:51 | 3/27/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S | -1,179 | 81.13 | 0 | -15 | -17 | 73 | D | | | | | | | | | | | | | | |
3/29/23 17:48 | 3/27/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | M.d | 134 | 19.11 | 0 | 7 | 14 | 56 | D | | | | | | | | | | | | | | |
3/29/23 17:48 | 3/27/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S.d | -566 | 80.75 | 0 | -7 | -11 | 56 | D | | | | | | | | | | | | | | |
3/17/23 16:30 | 3/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -28 | 71.58 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
3/17/23 16:30 | 3/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -358 | 71.58 | 0 | -5 | -4 | 128 | D | | | | | | | | | | | | | | |
3/10/23 17:08 | 3/8/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -752 | 74.70 | 0 | -10 | -1 | 719 | D | | | | | | | | | | | | | | |
3/8/23 18:47 | 3/6/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | COO | S.m | -580 | 72.42 | 0 | -8 | -8 | 86 | D | | | | | | | | | | | | | | |
3/8/23 18:46 | 3/6/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S.m | -1,844 | 72.48 | 0 | -25 | -16 | 133 | D | | | | | | | | | | | | | | |
3/8/23 18:45 | 3/6/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S.m | -1,284 | 72.48 | 0 | -18 | -17 | 87 | D | | | | | | | | | | | | | | |
3/8/23 18:44 | 3/6/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S.m | -735 | 72.52 | 0 | -10 | -12 | 75 | D | | | | | | | | | | | | | | |
3/8/23 18:44 | 3/6/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S.m | -628 | 72.52 | 0 | -9 | -12 | 63 | D | | | | | | | | | | | | | | |
3/6/23 21:09 | 3/3/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S.dm | -6,882 | 73.03 | 0 | -94 | -11 | 729 | D | | | | | | | | | | | | | | |
2/17/23 16:30 | 2/15/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -22 | 57.52 | 0 | 0 | -1 | 60 | D | | | | | | | | | | | | | | |
1/19/23 16:45 | 1/17/23 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -20 | 52.97 | 0 | 0 | -1 | 61 | D | | | | | | | | | | | | | | |
12/19/22 16:31 | 12/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 53.75 | 0 | 0 | -1 | 61 | D | | | | | | | | | | | | | | |
11/21/22 16:30 | 11/17/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | COO | S | -133 | 54.79 | 0 | -2 | -3 | 74 | D | | | | | | | | | | | | | | |
11/17/22 16:30 | 11/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -295 | 59.00 | 0 | -5 | -4 | 121 | D | | | | | | | | | | | | | | |
11/17/22 16:30 | 11/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -23 | 59.00 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
11/15/22 16:30 | 11/11/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -179 | 59.73 | 0 | -3 | -4 | 65 | D | | | | | | | | | | | | | | |
11/10/22 16:30 | 11/8/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -752 | 57.21 | 0 | -13 | -2 | 673 | D | | | | | | | | | | | | | | |
10/20/22 16:30 | 10/18/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S.m | -425 | 72.50 | 0 | -6 | -7 | 79 | D | | | | | | | | | | | | | | |
10/20/22 16:30 | 10/18/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -354 | 73.41 | 0 | -5 | -4 | 126 | D | | | | | | | | | | | | | | |
10/19/22 16:30 | 10/17/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -27 | 70.50 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
9/19/22 16:30 | 9/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -33 | 85.83 | 0 | 0 | -1 | 62 | D | | | | | | | | | | | | | | |
9/12/22 16:30 | 9/8/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | M.d | 450 | 18.40 | 0 | 24 | 300 | 33 | D | | | | | | | | | | | | | | |
9/12/22 16:30 | 9/8/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S.d | -3,522 | 84.24 | 0 | -42 | -56 | 33 | D | | | | | | | | | | | | | | |
9/8/22 16:30 | 9/6/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | | S | -338 | 78.50 | 0 | -4 | -14 | 26 | D | | | | | | | | | | | | | | |
9/8/22 16:30 | 9/6/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | M.d | 33 | 19.78 | 0 | 2 | 4 | 50 | D | | | | | | | | | | | | | | |
9/8/22 16:30 | 9/6/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S.d | -133 | 78.50 | 0 | -2 | -3 | 50 | D | | | | | | | | | | | | | | |
8/22/22 16:30 | 8/18/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | COO | S | -125 | 83.39 | 0 | -2 | -2 | 76 | D | | | | | | | | | | | | | | |
8/17/22 19:43 | 8/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -32 | 82.82 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
8/17/22 19:42 | 8/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -414 | 82.82 | 0 | -5 | -4 | 131 | D | | | | | | | | | | | | | | |
8/15/22 17:03 | 8/11/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -248 | 82.66 | 0 | -3 | -4 | 68 | D | | | | | | | | | | | | | | |
8/10/22 16:30 | 8/8/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -752 | 79.69 | 0 | -9 | -1 | 686 | D | | | | | | | | | | | | | | |
7/19/22 16:30 | 7/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S.m | -105 | 70.86 | 0 | -1 | -2 | 63 | D | | | | | | | | | | | | | | |
6/17/22 16:31 | 6/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -24 | 62.87 | 0 | 0 | -1 | 64 | D | | | | | | | | | | | | | | |
5/20/22 16:30 | 5/18/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -89 | 64.54 | 0 | -1 | -2 | 71 | D | | | | | | | | | | | | | | |
5/18/22 16:30 | 5/16/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -633 | 63.27 | 0 | -10 | -7 | 136 | D | | | | | | | | | | | | | | |
5/17/22 16:33 | 5/13/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | Chief Co | S | -139 | 60.95 | 0 | -2 | -74 | 1 | D | | | | | | | | | | | | | | |
5/13/22 16:31 | 5/11/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | | S | -172 | 57.84 | 0 | -3 | -9 | 31 | D | | | | | | | | | | | | | | |
5/12/22 17:25 | 5/10/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Ber Gerard | MA | D | | S | -74 | 58.19 | 0 | -1 | -4 | 33 | D | | | | | | | | | | | | | | |
5/11/22 16:30 | 5/9/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -751 | 61.19 | 0 | -12 | -2 | 695 | D | | | | | | | | | | | | | | |
4/6/22 16:30 | 4/4/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S | -726 | 57.38 | 0 | -13 | -13 | 84 | D | | | | | | | | | | | | | | |
4/4/22 16:30 | 3/31/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | M.d | 102 | 23.04 | 0 | 4 | 9 | 54 | D | | | | | | | | | | | | | | |
4/1/22 16:30 | 3/30/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Walker Carol | MA | O | SVP,Qual | S | -843 | 56.22 | 0 | -15 | -19 | 65 | D | | | | | | | | | | | | | | |
3/9/22 16:30 | 3/7/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S.m | -92 | 52.08 | 0 | -2 | -2 | 73 | D | | | | | | | | | | | | | | |
3/9/22 16:30 | 3/7/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | Chief Co | S | -117 | 52.55 | 0 | -2 | -3 | 76 | D | | | | | | | | | | | | | | |
3/9/22 16:30 | 3/7/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -230 | 52.55 | 0 | -4 | -3 | 146 | D | | | | | | | | | | | | | | |
3/9/22 16:30 | 3/7/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Walker Carol | MA | O | SVP,Qual | S | -84 | 52.55 | 0 | -2 | -2 | 80 | D | | | | | | | | | | | | | | |
3/9/22 16:30 | 3/7/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S | -164 | 52.55 | 0 | -3 | -3 | 97 | D | | | | | | | | | | | | | | |
3/9/22 16:30 | 3/7/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S.m | -84 | 52.08 | 0 | -2 | -2 | 65 | D | | | | | | | | | | | | | | |
3/7/22 20:45 | 3/4/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S.d | -128 | 49.98 | 0 | -3 | -2 | 150 | D | | | | | | | | | | | | | | |
3/7/22 20:45 | 3/4/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | Chief Co | S.d | -196 | 49.98 | 0 | -4 | -5 | 79 | D | | | | | | | | | | | | | | |
3/7/22 20:42 | 3/4/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S.d | -82 | 49.98 | 0 | -2 | -2 | 100 | D | | | | | | | | | | | | | | |
3/7/22 20:41 | 3/4/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Walker Carol | MA | O | SVP,Qual | S.d | -77 | 49.98 | 0 | -2 | -2 | 81 | D | | | | | | | | | | | | | | |
3/7/22 20:38 | 3/3/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S.dm | -1,205 | 51.63 | 0 | -23 | -3 | 707 | D | | | | | | | | | | | | | | |
3/2/22 21:09 | 3/1/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -116 | 48.04 | 0 | -2 | -4 | 61 | D | | | | | | | | | | | | | | |
3/2/22 21:08 | 3/1/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Walker Carol | MA | O | SVP,Qual | S | -334 | 48.04 | 0 | -7 | -8 | 76 | D | | | | | | | | | | | | | | |
3/2/22 21:07 | 3/1/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -425 | 48.04 | 0 | -9 | -7 | 127 | D | | | | | | | | | | | | | | |
3/2/22 21:06 | 2/28/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -2,042 | 46.50 | 0 | -44 | -6 | 656 | D | | | | | | | | | | | | | | |
3/2/22 21:05 | 3/1/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S | -288 | 48.04 | 0 | -6 | -7 | 84 | D | | | | | | | | | | | | | | |
3/2/22 21:03 | 3/1/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -127 | 48.04 | 0 | -3 | -4 | 59 | D | | | | | | | | | | | | | | |
2/17/22 16:30 | 2/15/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -36 | 28.64 | 0 | -1 | -2 | 60 | D | | | | | | | | | | | | | | |
1/20/22 16:30 | 1/18/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -33 | 26.93 | 0 | -1 | -2 | 61 | D | | | | | | | | | | | | | | |
1/5/22 16:43 | 1/3/22 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -403 | 28.61 | 0 | -14 | -2 | 661 | D | | | | | | | | | | | | | | |
12/17/21 16:30 | 12/15/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -33 | 26.72 | 0 | -1 | -2 | 62 | D | | | | | | | | | | | | | | |
11/17/21 16:30 | 11/15/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -38 | 30.47 | 0 | -1 | -2 | 64 | D | | | | | | | | | | | | | | |
11/15/21 16:05 | 11/10/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 30.12 | 0 | -13 | -2 | 675 | D | | | | | | | | | | | | | | |
10/20/21 16:33 | 10/18/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S.m | -94 | 22.92 | 0 | -4 | -5 | 84 | D | | | | | | | | | | | | | | |
10/20/21 16:31 | 10/18/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S.m | -218 | 22.92 | 0 | -10 | -7 | 127 | D | | | | | | | | | | | | | | |
10/19/21 16:30 | 10/15/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -29 | 23.71 | 0 | -1 | -2 | 65 | D | | | | | | | | | | | | | | |
9/17/21 16:30 | 9/15/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -30 | 24.55 | 0 | -1 | -2 | 66 | D | | | | | | | | | | | | | | |
9/10/21 16:30 | 9/8/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S | -12 | 26.06 | 0 | 0 | -1 | 87 | D | | | | | | | | | | | | | | |
8/18/21 17:10 | 8/16/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -32 | 25.46 | 0 | -1 | -2 | 67 | D | | | | | | | | | | | | | | |
8/12/21 16:30 | 8/10/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 25.83 | 0 | -16 | -2 | 688 | D | | | | | | | | | | | | | | |
6/21/21 16:31 | 6/16/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Bolla John J. | MA | O | Chief Op | S | -55 | 24.37 | 0 | -2 | -2 | 102 | D | | | | | | | | | | | | | | |
6/8/21 16:30 | 6/4/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | S | -183 | 24.60 | 0 | -7 | -8 | 88 | D | | | | | | | | | | | | | | |
4/20/21 16:30 | 4/16/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -163 | 21.75 | 0 | -8 | -6 | 109 | D | | | | | | | | | | | | | | |
4/14/21 16:30 | 4/12/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -401 | 20.66 | 0 | -19 | -3 | 704 | D | | | | | | | | | | | | | | |
4/13/21 16:30 | 4/9/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | | S | -59 | 21.22 | 0 | -3 | -11 | 23 | D | | | | | | | | | | | | | | |
4/12/21 16:30 | 4/8/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S | -106 | 21.17 | 0 | -5 | -11 | 41 | D | | | | | | | | | | | | | | |
3/9/21 21:07 | 3/5/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | P | 19 | 18.60 | 0 | 1 | 7 | 16 | D | | | | | | | | | | | | | | |
3/9/21 21:06 | 3/5/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -496 | 18.26 | 0 | -27 | -4 | 723 | D | | | | | | | | | | | | | | |
3/8/21 21:09 | 3/4/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | Chief Co | S | -75 | 18.40 | 0 | -4 | -6 | 60 | D | | | | | | | | | | | | | | |
3/8/21 21:07 | 3/4/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Bolla John J. | MA | O | Chief Op | S | -35 | 18.40 | 0 | -2 | -2 | 105 | D | | | | | | | | | | | | | | |
3/8/21 21:05 | 3/4/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S.m | -128 | 18.97 | 0 | -7 | -5 | 117 | D | | | | | | | | | | | | | | |
3/8/21 20:48 | 3/4/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -42 | 18.40 | 0 | -2 | -2 | 137 | D | | | | | | | | | | | | | | |
3/8/21 20:40 | 3/4/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Molnar Istvan | MA | O | Chief Me | S | -74 | 18.40 | 0 | -4 | -6 | 59 | D | | | | | | | | | | | | | | |
3/3/21 16:30 | 3/1/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -28 | 19.08 | 0 | -1 | -1 | 102 | D | | | | | | | | | | | | | | |
3/3/21 16:30 | 3/1/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Bolla John J. | MA | O | Chief Op | S | -23 | 19.08 | 0 | -1 | -2 | 59 | D | | | | | | | | | | | | | | |
3/3/21 16:30 | 3/1/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -28 | 19.08 | 0 | -1 | -2 | 79 | D | | | | | | | | | | | | | | |
3/2/21 16:30 | 2/26/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | P | 18 | 18.02 | 0 | 1 | 7 | 15 | D | | | | | | | | | | | | | | |
2/23/21 16:30 | 2/19/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | P | 19 | 19.39 | 0 | 1 | 8 | 14 | D | | | | | | | | | | | | | | |
2/17/21 16:30 | 2/12/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | P | 20 | 20.03 | 0 | 1 | 8 | 13 | D | | | | | | | | | | | | | | |
2/9/21 16:30 | 2/5/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | P | 18 | 17.94 | 0 | 1 | 9 | 12 | D | | | | | | | | | | | | | | |
2/2/21 16:30 | 1/29/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | P | 16 | 16.13 | 0 | 1 | 10 | 11 | D | | | | | | | | | | | | | | |
1/26/21 16:30 | 1/22/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | P | 15 | 15.29 | 0 | 1 | 11 | 10 | D | | | | | | | | | | | | | | |
1/20/21 16:30 | 1/15/21 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | P | 16 | 15.80 | 0 | 1 | 12 | 9 | D | | | | | | | | | | | | | | |
12/11/20 16:30 | 12/9/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -210 | 14.00 | 0 | -15 | -13 | 103 | D | | | | | | | | | | | | | | |
10/20/20 16:30 | 10/16/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -67 | 13.20 | 0 | -5 | -6 | 81 | D | | | | | | | | | | | | | | |
10/8/20 16:30 | 10/6/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -210 | 14.00 | 0 | -15 | -11 | 118 | D | | | | | | | | | | | | | | |
7/27/20 16:30 | 7/23/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -48 | 16.02 | 0 | -3 | 0 | 605 | D | | | | | | | | | | | | | | |
7/17/20 16:30 | 7/15/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -354 | 16.01 | 0 | -22 | -4 | 608 | D | | | | | | | | | | | | | | |
6/18/20 16:30 | 6/16/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Bolla John J. | MA | O | Chief Op | S | -35 | 14.29 | 0 | -2 | -4 | 60 | D | | | | | | | | | | | | | | |
4/30/20 18:35 | 4/28/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -95 | 13.13 | 0 | -7 | -5 | 133 | D | | | | | | | | | | | | | | |
4/29/20 16:30 | 4/27/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -413 | 13.77 | 0 | -30 | -5 | 634 | D | | | | | | | | | | | | | | |
3/10/20 16:30 | 3/6/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -28 | 14.58 | 0 | -2 | -1 | 141 | D | | | | | | | | | | | | | | |
3/5/20 16:31 | 3/5/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -138 | 15.35 | 0 | -9 | -1 | 664 | D | | | | | | | | | | | | | | |
3/2/20 16:34 | 2/27/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S.m | -38 | 15.66 | 0 | -2 | -5 | 51 | D | | | | | | | | | | | | | | |
3/2/20 16:34 | 2/27/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | | S | -28 | 15.86 | 0 | -2 | -10 | 16 | D | | | | | | | | | | | | | | |
3/2/20 16:33 | 2/27/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Bolla John J. | MA | O | Chief Op | S | -20 | 15.79 | 0 | -1 | -3 | 35 | D | | | | | | | | | | | | | | |
3/2/20 16:32 | 2/27/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S | -43 | 15.85 | 0 | -3 | -7 | 35 | D | | | | | | | | | | | | | | |
3/2/20 16:30 | 2/27/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Robertson A Frederick | MA | D | | S | -42 | 15.86 | 0 | -3 | -6 | 40 | D | | | | | | | | | | | | | | |
3/2/20 16:30 | 2/27/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -25 | 15.79 | 0 | -2 | -1 | 116 | D | | | | | | | | | | | | | | |
2/28/20 16:32 | 2/26/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S.m | -514 | 16.27 | 0 | -32 | -6 | 524 | D | | | | | | | | | | | | | | |
2/26/20 16:30 | 2/24/20 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -159 | 16.06 | 0 | -10 | -2 | 556 | D | | | | | | | | | | | | | | |
12/23/19 16:30 | 12/20/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 20.85 | 0 | -19 | -3 | 563 | D | | | | | | | | | | | | | | |
12/18/19 16:31 | 12/16/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -132 | 20.82 | 0 | -6 | -11 | 53 | D | | | | | | | | | | | | | | |
12/17/19 16:31 | 12/13/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S | -234 | 20.30 | 0 | -12 | -23 | 38 | D | | | | | | | | | | | | | | |
11/18/19 16:30 | 11/14/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -156 | 20.79 | 0 | -8 | -6 | 124 | D | | | | | | | | | | | | | | |
10/18/19 16:30 | 10/16/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -92 | 19.07 | 0 | -5 | -7 | 60 | D | | | | | | | | | | | | | | |
9/24/19 16:30 | 9/20/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 25.81 | 0 | -16 | -3 | 582 | D | | | | | | | | | | | | | | |
9/16/19 16:30 | 9/12/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -178 | 23.74 | 0 | -8 | -5 | 131 | D | | | | | | | | | | | | | | |
9/6/19 16:30 | 9/4/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -115 | 20.60 | 0 | -6 | -4 | 139 | D | | | | | | | | | | | | | | |
9/5/19 16:30 | 9/3/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -542 | 21.21 | 0 | -26 | -4 | 598 | D | | | | | | | | | | | | | | |
7/12/19 16:13 | 7/10/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | SVP,GC | S | -248 | 28.14 | 0 | -9 | -6 | 144 | D | | | | | | | | | | | | | | |
7/12/19 16:05 | 7/10/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -138 | 28.07 | 0 | -5 | -15 | 28 | D | | | | | | | | | | | | | | |
7/10/19 16:05 | 7/8/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Orlandi Cesare | MA | O | Chief Me | M.d | 751 | 21.10 | 0 | 36 | 108 | 68 | D | | | | | | | | | | | | | | |
7/10/19 16:05 | 7/8/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Orlandi Cesare | MA | O | Chief Me | S.d | -1,003 | 28.17 | 0 | -36 | -34 | 68 | D | | | | | | | | | | | | | | |
7/5/19 16:05 | 7/3/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -142 | 28.41 | 0 | -5 | -13 | 32 | D | | | | | | | | | | | | | | |
6/28/19 16:30 | 6/26/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -138 | 27.67 | 0 | -5 | -12 | 37 | D | | | | | | | | | | | | | | |
6/27/19 16:38 | 6/18/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Bolla John J. | MA | O | Chief Op | S.a | -62 | 27.58 | 0 | -2 | -6 | 36 | D | | | | | | | | | | | | | | |
6/24/19 16:30 | 6/20/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -400 | 27.89 | 0 | -14 | -2 | 623 | D | | | | | | | | | | | | | | |
6/21/19 16:30 | 6/19/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -137 | 27.40 | 0 | -5 | -11 | 42 | D | | | | | | | | | | | | | | |
6/20/19 16:32 | 6/18/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Bolla John J. | MA | O | Chief Op | S.m | -48 | 27.56 | 0 | -2 | -5 | 37 | D | | | | | | | | | | | | | | |
6/14/19 16:30 | 6/12/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -126 | 25.27 | 0 | -5 | -10 | 47 | D | | | | | | | | | | | | | | |
6/11/19 16:32 | 6/7/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S | -100 | 25.33 | 0 | -4 | -7 | 50 | D | | | | | | | | | | | | | | |
6/7/19 16:30 | 6/5/19 | LNTH | Health | Health | Misc Health & Allied Services | Schaffer Derace L | MA | D | | S | -247 | 24.71 | 0 | -10 | -37 | 17 | D | | | | | | | | | | | | | | |
6/7/19 16:30 | 6/5/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -123 | 24.60 | 0 | -5 | -9 | 52 | D | | | | | | | | | | | | | | |
6/5/19 16:30 | 6/3/19 | LNTH | Health | Health | Misc Health & Allied Services | Schaffer Derace L | MA | D | | S.m | -476 | 23.82 | 0 | -20 | -43 | 27 | D | | | | | | | | | | | | | | |
5/31/19 16:30 | 5/29/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -121 | 24.29 | 0 | -5 | -8 | 57 | D | | | | | | | | | | | | | | |
5/24/19 16:30 | 5/22/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -124 | 24.73 | 0 | -5 | -7 | 62 | D | | | | | | | | | | | | | | |
5/22/19 16:30 | 5/20/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 23.89 | 0 | -17 | -3 | 638 | D | | | | | | | | | | | | | | |
5/17/19 16:31 | 5/15/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -124 | 24.75 | 0 | -5 | -7 | 67 | D | | | | | | | | | | | | | | |
5/10/19 16:31 | 5/8/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -126 | 25.22 | 0 | -5 | -6 | 72 | D | | | | | | | | | | | | | | |
5/2/19 16:30 | 4/30/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S.m | -241 | 24.11 | 0 | -10 | -11 | 77 | D | | | | | | | | | | | | | | |
5/1/19 16:30 | 4/29/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | See Rema | S | -172 | 24.84 | 0 | -7 | -4 | 153 | D | | | | | | | | | | | | | | |
5/1/19 16:30 | 4/29/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Orlandi Cesare | MA | O | Chief Me | S | -280 | 24.85 | 0 | -11 | -14 | 68 | D | | | | | | | | | | | | | | |
4/30/19 16:30 | 4/26/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -741 | 24.86 | 0 | -30 | -4 | 655 | D | | | | | | | | | | | | | | |
4/25/19 16:30 | 4/23/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -120 | 24.07 | 0 | -5 | -5 | 87 | D | | | | | | | | | | | | | | |
4/18/19 16:30 | 4/16/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | S | -126 | 25.26 | 0 | -5 | -5 | 92 | D | | | | | | | | | | | | | | |
4/16/19 16:30 | 4/12/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -401 | 25.40 | 0 | -16 | -2 | 684 | D | | | | | | | | | | | | | | |
4/3/19 16:30 | 4/1/19 | LNTH | Health | Health | Misc Health & Allied Services | Schaffer Derace L | MA | D | | S | -244 | 24.41 | 0 | -10 | -18 | 47 | D | | | | | | | | | | | | | | |
3/8/19 16:35 | 3/6/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Orlandi Cesare | MA | O | Chief Me | S | -97 | 22.77 | 0 | -4 | -5 | 80 | D | | | | | | | | | | | | | | |
3/8/19 16:33 | 3/6/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | | S | -59 | 22.77 | 0 | -3 | -13 | 18 | D | | | | | | | | | | | | | | |
3/8/19 16:32 | 3/6/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Pruden Gary J | MA | D | | S | -73 | 22.77 | 0 | -3 | -24 | 10 | D | | | | | | | | | | | | | | |
3/8/19 16:32 | 3/6/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | See Rema | S | -41 | 22.77 | 0 | -2 | -1 | 160 | D | | | | | | | | | | | | | | |
3/8/19 16:32 | 3/6/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Thrall James H | MA | D | | S | -80 | 22.78 | 0 | -4 | -26 | 10 | D | | | | | | | | | | | | | | |
3/8/19 16:30 | 3/6/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Robertson A Frederick | MA | D | | S | -90 | 22.77 | 0 | -4 | -8 | 43 | D | | | | | | | | | | | | | | |
3/6/19 16:30 | 3/4/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S.m | -217 | 23.35 | 0 | -9 | -1 | 700 | D | | | | | | | | | | | | | | |
2/28/19 16:17 | 2/27/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Duffy Michael P | MA | O | See Rema | S | -55 | 23.17 | 0 | -2 | -1 | 162 | D | | | | | | | | | | | | | | |
2/28/19 16:15 | 2/27/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Orlandi Cesare | MA | O | Chief Me | S | -72 | 23.10 | 0 | -3 | -4 | 84 | D | | | | | | | | | | | | | | |
2/27/19 16:16 | 2/25/19 | LNTH | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -228 | 24.06 | 0 | -9 | -1 | 709 | D | | | | | | | | | | | | | | |